Use of gastrointestinal prophylaxis in NSAID patients: A cross sectional study in community pharmacies

International Journal of Clinical Pharmacy

Volumn 33, Issue 2, 2011, Pages 155-164

  López Pintor, Elsa ^a   Lumbreras, Blanca ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Community pharmacy; Gastroprotective drugs; Non Steroidal Antiinflammatory Drugs; OTCdrugs; Risk factors; Spain

Indexed keywords

ACETIC ACID DERIVATIVE; HISTAMINE H2 RECEPTOR ANTAGONIST; MISOPROSTOL; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; OXICAM DERIVATIVE; PROPIONIC ACID DERIVATIVE; PROTON PUMP INHIBITOR; SALICYLIC ACID;

ADULT; ARTICLE; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; COMMUNITY ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG ABUSE; DRUG MONITORING; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TOXICITY; HEALTH CARE ACCESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SELF MEDICATION; STOMACH DISEASE; STOMACH PROTECTION; STOMACH ULCER;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATTITUDE OF HEALTH PERSONNEL; COMMUNITY PHARMACY SERVICES; CONSUMER PRODUCT SAFETY; CROSS-SECTIONAL STUDIES; FEMALE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL DISEASES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NONPRESCRIPTION DRUGS; ODDS RATIO; PATIENT EDUCATION AS TOPIC; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SPAIN;

EID: 79960158185     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-011-9490-5     Document Type: Article

References (24)

1. Balbuena FR, Aranda AB, Figueras A. Self-medication in older urban mexicans: an observational, descriptive, cross-sectional study. Drugs Aging. 2009;26:51-60.
2. Paulose-Ram R, Hirsch R, Dillon C, Gu Q. Frequent monthly use of selected non-prescription and prescription non-narcotic analgesics among US adults. Pharmacoepidemiol Drug Saf. 2005;14:257-66. (Pubitemid 40528855)
3. Singh G, Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol SUPPL.. 1999;56:18-24. (Pubitemid 29183022)
4. De Abajo F, García Del Pozo J, Del Pino A. Trends of NonSteroidal anti-inflammatory drugs use in Spain, 1990 through 2003. Aten Primaria. 2005;36:424-33.
5. Dirección General de Farmacia y Productos Sanitarios. Prestación Farmacéutica y Ortoprotésica de la Comunitat Valenciana, 2009;3.
6. Lanas A, Perez-Aisa MA, Feu F, Ponce J, Saperas E, Santolaria S, et al. Investigators of the Asociación Española de Gastroenterologí a (AEG). A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use. Am J Gastroenterol. 2005;100:1685-93. (Pubitemid 41648418)
7. Patterson MK, Castellsague J, Walker AM. Hospitalization for peptic ulcer and bleeding in users of selective COX-2 inhibitors and nonselective NSAIDs with special reference to celecoxib. Pharmacoepidemiol Drug Saf. 2008;10:982-8.
8. Rahme E, Barkun A, Nedjar H, Gaugris S, Watson D. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada. Am J Gastroenterol. 2008;103:872-82. (Pubitemid 351501121)
9. Rivkin A. Admissions to a medical intensive care unit related to adverse drug reactions. Am J Health Syst Pharm. 2007;64:1840-3. (Pubitemid 350202217)
10. Lanas A, Tornero J, Zamorano JL. Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA study. Ann Rheum Dis. 2010;69:1453-8.
11. Lanas A. Cost stratification of nonsteroidal anti-inflammatory drug-associated gastrointestinal side effects. Med Clin (Barc) 2000;114(3):46-53.
12. Hallas J, Jensen KB, Grodum E, Damsbo N, Gram LF. Drugrelated admissions to a department of medical gastroenterology. The role of self-medicated and prescribed drugs. Scand J Gastroenterol. 1991;26:174-80.
13. Association of the European Self-Medication Industry. The economic and public health value of self medication 2004: http://www.aesgp.be/ephv/2004study. pdf. Accessed 7 Feb 2011.
14. Knijff-Dutmer EA, Schut GA, Van de Laar MA. Concomitant coumarin-NSAID therapy and risk for bleeding. Ann Pharmacother. 2002;37:12-6.
15. Lanza FL, Chan FK, Quigley EM. Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009;104:728-38.
16. Rostom A, Dube C, Wells G, Tugwell P, Welch V, Jolicoeur E et al. Prevention of NSAID-induced gastroduodenal ulcers. Cochrane Database Syst Rev 2002;4:CD002296.
17. Arboleya LR, De la Figuera E, García M, Aragón B, VICOXX Study Group. Management pattern for patients with osteoarthritis treated with traditional non-steroidal anti-inflammatory drugs in Spain prior to introduction of Coxibs. Curr Med Res Opin 2003;19:278-287. (Pubitemid 36827836)
18. Hartnell NR, Flanagan PS, MacKinnon NJ, Bakowsky VS. Use of gastrointestinal preventive therapy among elderly persons receiving antiarthritic agents in Nova Scotia, Canada. Am J Geriatr Pharmacother. 2004;2:171-80. (Pubitemid 39618442)
19. Henry D, Lim LL, Garcia Rodriguez LA, Perez Gutthann S, Carson JL, Griffin M, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ. 1996;312:1563-6. (Pubitemid 26188573)
20. Clinard F, Bardou M, Sgro C, Lefevre N, Raphael F, Paille F. Non-steroidal anti-inflammatory and cytoprotective drug co-prescription in general practice. A general practitioner-based survey in France. Eur J Clin Pharmacol. 2001;57:737-43. (Pubitemid 34031267)
21. Barkin RL. The pharmacist's role in the nonsteroidal antiinflammatory drug selection process. Am J Ther. 2008;15:S17-9.
22. Glew CM, Rentler RJ. Use of proton pump inhibitors and other acid suppressive medications in newly admitted nursing facility patients. J Am Med Dir Assoc. 2007;8:607-9. (Pubitemid 350056386)
23. Roux C, Briot K, Gossec L, Kolta S, Blenk T, Felsenberg D, et al. Increase in vertebral fracture risk in postmenopausal women using omeprazole. Calcif Tissue Int. 2009;84:13-9.
24. Van Dijk KN, Ter Huurne K, De Vries CS, Van den Berg PB, Brouwers JR, De Jong-van den Berg LT. Prescribing of gastroprotective drugs among elderly NSAID users in The Netherlands. Pharm World Sci. 2002;24:100-3. (Pubitemid 34754763)